OSPOLOT

This brand name is authorized in Austria, Australia, Estonia, Israel, Japan, Lithuania

Active ingredients

The drug OSPOLOT contains one active pharmaceutical ingredient (API):

1 Sultiame UNII I00Q766CZ2 - SULTHIAME

Sultiame is indicated as an anticonvulsant for behavioural disorders associated with epilepsy; hyperkinetic behaviour; temporal lobe epilepsy; myoclonic seizures; grand mal attacks; Jacksonian seizures. Read about Sultiame

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX03	Sultiame	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2099L, 2100M
Country: EE	Ravimiamet	Identifier(s): 1423909
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2977
Country: JP	医薬品医療機器総合機構	Identifier(s): 1137001F1039, 1137001F2035
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004589, 1068692, 1091728